| 5-R01-EB036085-02 |
Engineering recombinase circuits for cellular diagnostic devices |
Wilson Wong |
Boston University (Charles River Campus) |
| 5-R01-EB036003-02 |
Engineering therapeutic cellular functions using robust and highly programmable extrachromosomal genetic technologies |
Isaac Hilton |
Rice University |
| 5-R21-EB033121-03 |
Glia Exclusive Gene Therapy |
Or Shemesh |
University of Pittsburgh at Pittsburgh |
| 5-R01-EB033389-03 |
Homogenized, engineered extracellular vesicles for intracranial targeting |
Randy Carney |
University of California at Davis |
| 5-K08-EB036081-02 |
In vivo enrichment of cell-free DNA to boost sensitivity of circulating nucleic-acid based diagnostics |
Shervin Tabrizi |
Massachusetts General Hospital |
| 1-R21-EB033963-01A1 |
Mitigating the Immunogenicity of Engineered Aav Gene Delivery Vectors by Biomaterial-Driven Immunosuppression |
Shaoyi Jiang |
Cornell University |
| 1-R15-EB035866-01 |
Mitochondrial-targeting Exosomes for Neuroinflammation |
Lanrong Bi |
Michigan Technological University |
| 5-R01-EB031904-04 |
Multiplexed and Logical Control of the Mammalian Transcriptome Using Cas13 |
Wilson Wong |
Boston University (Charles River Campus) |
| 5-R21-EB034346-02 |
Next generation of delivery platform for Prime editors based on an RNA vector for Sickle cell disease: the “all-in-one” vector |
Patricia Devaux |
Mayo Clinic Rochester |
| 5-R01-EB033676-04 |
Next generation transposon vectors for genome engineering |
Matthew Wilson |
Vanderbilt University Medical Center |
